Search Results - "Tomlinson, Ursula"
-
1
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Published in Journal of hematology and oncology (12-11-2022)“…Abstract Background The prognosis for metastatic and recurrent tumors of the central nervous system (CNS) remains dismal, and the need for newer therapeutic…”
Get full text
Journal Article -
2
IMMU-05. SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3
Published in Neuro-oncology (Charlottesville, Va.) (22-06-2018)“…Abstract BACKGROUND Tumors metastasizing to the CNS are associated with significant mortality. We tested the toxicity and dosimetry of intraventricular…”
Get full text
Journal Article -
3
-
4
SCDT-38. SAFETY AND EFFICACY OF INTRAVENTRICULAR 131I-LABELED MONOCLONAL ANTIBODY 8H9 TARGETING THE SURFACE GLYCOPROTEIN B7-H3 IN PATIENTS WITH CNS/LM DISEASE
Published in Neuro-oncology (Charlottesville, Va.) (06-11-2017)“…Tumors metastasizing to the central nervous system (CNS) are associated with significant mortality. We tested the toxicity and dosimetry of intraventricular…”
Get full text
Journal Article -
5
A curative approach to central nervous system metastases of neuroblastoma
Published in Journal of clinical oncology (20-05-2017)“…Abstract only 10545 Background: Neuroblastoma metastatic to the central nervous system (CNS NB) is associated with significant mortality (median survival < 6…”
Get full text
Journal Article -
6
Phase 1 study of intraventricular 131 I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Published in Journal of hematology and oncology (12-11-2022)“…The prognosis for metastatic and recurrent tumors of the central nervous system (CNS) remains dismal, and the need for newer therapeutic targets and modalities…”
Get full text
Journal Article